AHA Scientific Sessions 2026 AbstractNov 7, 2026, 02:04 GMT

Fewer deaths linked to therapy in new lower-risk atrial fibrillation

Among patients classified as low risk by one stroke score, death rates were 3.16 with oral anticoagulants versus 3.66 without clot-preventing medicines per 100 patient-years.

Paper by Riccardo Cappato · IRCCS Multimedica

Upright people surround a cross-sectioned heart, with more white gaps in the group on gray ground and matching marked brains below.

Our read

Interventions

Studied:: Cohort study of 196,779 adults with newly diagnosed atrial fibrillation, median 5.9 years
What changed:: Low-risk patients taking anticoagulants had lower death rates: 3.16 versus 3.66 per 100 patient-years without clot-preventing medicines
The catch:: Differences in health or care between treatment groups could account for lower death rates
In the record:: The 31st paper on oral anticoagulants with results in people; 61 on record in all. Its result on mortality agrees with 8 of 10 other findings on record; 2 found no change.
Why it’s aging research:: It measures an outcome that worsens with age.

Editor of record: Boris Djordjevic · AgingResearch.News

Paper

UK adults newly diagnosed with atrial fibrillation, an irregular heartbeat, were studied in an observational analysis of linked health records. The 196,779 patients averaged 75.8 years old; 49.1% were women. Researchers compared people prescribed oral anticoagulants, medicines that reduce blood clotting, with groups receiving other clot-preventing medicines or none.

Over a median 5.9 years, immediate, continuous anticoagulant use was associated with lower death rates in low- and moderate-stroke-risk groups after adjustment for age, sex and other illnesses. Under one stroke-risk scoring system, moderate-risk patients had death rates of 5.49 with anticoagulants versus 11.41 without clot-preventing medicines per 100 patient-years. Anticoagulant use was not associated with a statistically significant reduction in strokes in any risk category examined.

Why it matters

For older adults with atrial fibrillation, uncertainty about anticoagulants at low-to-moderate stroke risk includes their possible role in survival, not just stroke prevention.

Caveats

People prescribed anticoagulants may have differed in health or care from those receiving no clot-preventing medicines, despite statistical adjustments. The conference abstract did not report bleeding outcomes, and 97.6% of participants were white.